Literature DB >> 9610866

The prognostic significance of c-myc oncogene expression in uveal melanoma.

J S Chana1, I A Cree, A J Foss, J L Hungerford, G D Wilson.   

Abstract

The role of the c-myc oncogene has been little investigated in uveal melanoma. In this study an analysis of c-myc oncoprotein expression was undertaken using flow cytometry in 71 patients with posterior uveal melanoma. Nuclear c-myc oncoprotein was detected in all of the tumours, and survival analysis revealed a significant association between high oncoprotein positivity and improved survival (log rank test: chi2 = 6.47, P = 0.01). Multifactorial analysis using Cox's proportional hazards model revealed nuclear c-myc oncoprotein to be an independent prognostic marker more accurate than other clinicopathological parameters (log rank test: chi2 = 6.61, P = 0.01). However, this result of high oncoprotein expression correlating with improved outcome is surprising and in contrast to our previous studies using the same method on cutaneous melanoma, where high levels of nuclear c-myc expression have been found to correlate with poor outcome both in primary and secondary disease. This study suggests that the pattern of oncogene expression in uveal melanoma is distinct from cutaneous melanoma and that the underlying biology of these tumours is different.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9610866     DOI: 10.1097/00008390-199804000-00006

Source DB:  PubMed          Journal:  Melanoma Res        ISSN: 0960-8931            Impact factor:   3.599


  4 in total

1.  Deregulation of the Rb and p53 pathways in uveal melanoma.

Authors:  M A Brantley; J W Harbour
Journal:  Am J Pathol       Date:  2000-12       Impact factor: 4.307

2.  The relation between c-myc expression and interferon sensitivity in uveal melanoma.

Authors:  P N Tulley; M Neale; D Jackson; J S Chana; R Grover; I Cree; A O Grobbelaar; G D Wilson
Journal:  Br J Ophthalmol       Date:  2004-12       Impact factor: 4.638

3.  Combination chemotherapy for choroidal melanoma: ex vivo sensitivity to treosulfan with gemcitabine or cytosine arabinoside.

Authors:  M H Neale; N Myatt; I A Cree; C M Kurbacher; A J Foss; J L Hungerford; P N Plowman
Journal:  Br J Cancer       Date:  1999-03       Impact factor: 7.640

4.  Correlation of amplification and overexpression of the c-myc oncogene in high-grade breast cancer: FISH, in situ hybridisation and immunohistochemical analyses.

Authors:  J Blancato; B Singh; A Liu; D J Liao; R B Dickson
Journal:  Br J Cancer       Date:  2004-04-19       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.